Basic Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Jun 14, 2016; 22(22): 5173-5182
Published online Jun 14, 2016. doi: 10.3748/wjg.v22.i22.5173
Figure 1
Figure 1 Difference between viral load in responders to antiviral therapy (at 0 and 4 wk) vs non-responders (0 and 4 wk). No significant difference in the viral loads of responders vs non-responders at baseline, but when compared between baseline vs 4 wk (at RVR - rapid virological response) the viral load became undetectable in responders, while remained detectable in non-responders.